COMERA LIFE SCIENCES HOLDING (CMRA) Stock Price, Quote, News and Overview
NASDAQ:CMRA - Nasdaq - US20037C1080 - Common Stock - Currency: USD
CMRA Quote, Performance and Key Statistics
0.2227
-0.02 (-8.88%)
The current stock price of CMRA is 0.2227 USD. In the past month the price decreased by -16.28%. In the past year, price decreased by -83.38%.
CMRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About CMRA
Company Profile
Comera Life Sciences Holdings, Inc. engages in developing medicines. The company is headquartered in Woburn, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2020-12-15. The firm applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The firm is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. Its product programs include CLS-001, a preclinical stage bio better for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage bio better for various oncology indications. The company also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.
Company Info
COMERA LIFE SCIENCES HOLDING
12 Gill Street, Suite 4650
Woburn MASSACHUSETTS US
Employees: 12
Company Website: https://www.comeralifesciences.com/
Phone: 16178712101.0
COMERA LIFE SCIENCES HOLDING / CMRA FAQ
What is the stock price of COMERA LIFE SCIENCES HOLDING today?
The current stock price of CMRA is 0.2227 USD. The price decreased by -8.88% in the last trading session.
What is the ticker symbol for COMERA LIFE SCIENCES HOLDING stock?
The exchange symbol of COMERA LIFE SCIENCES HOLDING is CMRA and it is listed on the Nasdaq exchange.
On which exchange is CMRA stock listed?
CMRA stock is listed on the Nasdaq exchange.
What is COMERA LIFE SCIENCES HOLDING worth?
COMERA LIFE SCIENCES HOLDING (CMRA) has a market capitalization of 6.85M USD. This makes CMRA a Nano Cap stock.
How many employees does COMERA LIFE SCIENCES HOLDING have?
COMERA LIFE SCIENCES HOLDING (CMRA) currently has 12 employees.
What are the support and resistance levels for COMERA LIFE SCIENCES HOLDING (CMRA) stock?
COMERA LIFE SCIENCES HOLDING (CMRA) has a resistance level at 0.32. Check the full technical report for a detailed analysis of CMRA support and resistance levels.
Should I buy COMERA LIFE SCIENCES HOLDING (CMRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CMRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CMRA, evaluating the profitability, health, valuation and growth aspects
- COMERA LIFE SCIENCES HOLDING (CMRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COMERA LIFE SCIENCES HOLDING (CMRA) Sales and EPS estimates to see what analysts future expectations are.
- COMERA LIFE SCIENCES HOLDING (CMRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COMERA LIFE SCIENCES HOLDING (CMRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- COMERA LIFE SCIENCES HOLDING (CMRA) Stock Chart to make your own analysis
- COMERA LIFE SCIENCES HOLDING (CMRA) Latest news and press-releases to stay up to date.
Does COMERA LIFE SCIENCES HOLDING (CMRA) stock pay dividends?
CMRA does not pay a dividend.
What is the Price/Earnings (PE) ratio of COMERA LIFE SCIENCES HOLDING (CMRA)?
COMERA LIFE SCIENCES HOLDING (CMRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).
What is the Short Interest ratio of COMERA LIFE SCIENCES HOLDING (CMRA) stock?
The outstanding short interest for COMERA LIFE SCIENCES HOLDING (CMRA) is 0.04% of its float. Check the ownership tab for more information on the CMRA short interest.
CMRA Technical Analysis
CMRA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMRA. Both the profitability and financial health of CMRA have multiple concerns.
CMRA Financial Highlights
Over the last trailing twelve months CMRA reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS increased by 13.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -439.19% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |